Canntab Therapeutics Limited announced the appointment of Bob Woloschuk to its Advisory Board. Bob has over 20 years of pharmaceutical executive experience and has a keen eye for licensing opportunities, both in Canada and in international markets. In addition to Mr. Woloschuk, the Canntab Advisory Board is also comprised of: Sabrina Ramkellawan is the Vice President of the Clinical Research Association of Canada and the President of The Canadian Institute for Medical Advancement. She has 20 years of experience conducting clinical trials, including 7 studies on Cannabinoids and is known as a leader in the field. Hamish Sutherland is one of only a few individuals who has experience building a successful cannabis company. He was responsible for the first legal international transfer of live cannabis plant material from Holland to Canada, and was accountable for the 'greenfield' construction and commissioning of Bedrocan's automated facility, which was acquired by Tweed (now Canopy Growth) making it the leading cannabis company in Canada. Dr. Eric Hatashita, MD, CCFOP, FCFP, attended the University of Toronto Medical School and rose to become Chief Resident at Mt Sinai Hospital. Invited by the Kingdom of Saudi Arabia to assist in developing their Residency Training program, he lived and taught medicine overseas starting in 1996. Dr. Hatashita brings over 30 years of diverse medical experience to a private concierge medical practice, Regal Health Services Inc., and holds the highest honours in Family Medicine, the 'FCFP'.